| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 3937675
[patent_doc_number] => 05872005
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-02-16
[patent_title] => 'Packaging cell lines for adeno-associated viral vectors'
[patent_app_type] => 1
[patent_app_number] => 8/439586
[patent_app_country] => US
[patent_app_date] => 1995-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 19
[patent_no_of_words] => 9243
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/872/05872005.pdf
[firstpage_image] =>[orig_patent_app_number] => 439586
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/439586 | Packaging cell lines for adeno-associated viral vectors | May 11, 1995 | Issued |
Array
(
[id] => 3847814
[patent_doc_number] => 05766901
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-06-16
[patent_title] => 'Apparatus and method for delivering a nucleotide into cell nuclei'
[patent_app_type] => 1
[patent_app_number] => 8/434750
[patent_app_country] => US
[patent_app_date] => 1995-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 15
[patent_no_of_words] => 3260
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/766/05766901.pdf
[firstpage_image] =>[orig_patent_app_number] => 434750
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/434750 | Apparatus and method for delivering a nucleotide into cell nuclei | May 3, 1995 | Issued |
Array
(
[id] => 3723167
[patent_doc_number] => 05681745
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-10-28
[patent_title] => 'Biotin-binding containment systems'
[patent_app_type] => 1
[patent_app_number] => 8/432017
[patent_app_country] => US
[patent_app_date] => 1995-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 6701
[patent_no_of_claims] => 52
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/681/05681745.pdf
[firstpage_image] =>[orig_patent_app_number] => 432017
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/432017 | Biotin-binding containment systems | Apr 30, 1995 | Issued |
| 08/427348 | METHODS FOR SCREENING EXPRESSION LIBRARIES | Apr 23, 1995 | Abandoned |
Array
(
[id] => 3695859
[patent_doc_number] => 05677139
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-10-14
[patent_title] => 'In vitro differentiation of CD34.sup.+ progenitor cells into T lymphocytes'
[patent_app_type] => 1
[patent_app_number] => 8/426782
[patent_app_country] => US
[patent_app_date] => 1995-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10305
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/677/05677139.pdf
[firstpage_image] =>[orig_patent_app_number] => 426782
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/426782 | In vitro differentiation of CD34.sup.+ progenitor cells into T lymphocytes | Apr 20, 1995 | Issued |
Array
(
[id] => 3784841
[patent_doc_number] => 05736367
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-04-07
[patent_title] => 'Vectors and prokaryotes which autocatalytically delete antibiotic resistance'
[patent_app_type] => 1
[patent_app_number] => 8/425380
[patent_app_country] => US
[patent_app_date] => 1995-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 39
[patent_figures_cnt] => 42
[patent_no_of_words] => 9168
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/736/05736367.pdf
[firstpage_image] =>[orig_patent_app_number] => 425380
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/425380 | Vectors and prokaryotes which autocatalytically delete antibiotic resistance | Apr 19, 1995 | Issued |
| 08/424328 | GENE DELIVERY FUSION PROTEINS | Apr 16, 1995 | Abandoned |
Array
(
[id] => 4002241
[patent_doc_number] => 06004810
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-12-21
[patent_title] => 'Liver parenchymal cells having clonal growth ability, method for obtaining same, method for subculturing same, and subculturing system of primary hepatocytes'
[patent_app_type] => 1
[patent_app_number] => 8/419982
[patent_app_country] => US
[patent_app_date] => 1995-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 38
[patent_figures_cnt] => 53
[patent_no_of_words] => 6324
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 148
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/004/06004810.pdf
[firstpage_image] =>[orig_patent_app_number] => 419982
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/419982 | Liver parenchymal cells having clonal growth ability, method for obtaining same, method for subculturing same, and subculturing system of primary hepatocytes | Apr 10, 1995 | Issued |
Array
(
[id] => 3814879
[patent_doc_number] => 05789389
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-08-04
[patent_title] => 'BCL2 derived genetic elements associated with sensitivity to chemotherapeutic drugs'
[patent_app_type] => 1
[patent_app_number] => 8/405702
[patent_app_country] => US
[patent_app_date] => 1995-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 12787
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/789/05789389.pdf
[firstpage_image] =>[orig_patent_app_number] => 405702
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/405702 | BCL2 derived genetic elements associated with sensitivity to chemotherapeutic drugs | Mar 16, 1995 | Issued |
Array
(
[id] => 3699145
[patent_doc_number] => 05645991
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-07-08
[patent_title] => 'Transposon-containing DNA cloning vector and uses thereof'
[patent_app_type] => 1
[patent_app_number] => 8/403582
[patent_app_country] => US
[patent_app_date] => 1995-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5453
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/645/05645991.pdf
[firstpage_image] =>[orig_patent_app_number] => 403582
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/403582 | Transposon-containing DNA cloning vector and uses thereof | Mar 13, 1995 | Issued |
Array
(
[id] => 3934807
[patent_doc_number] => 05981177
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-11-09
[patent_title] => 'Protein fusion method and constructs'
[patent_app_type] => 1
[patent_app_number] => 8/378548
[patent_app_country] => US
[patent_app_date] => 1995-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 14
[patent_no_of_words] => 16340
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/981/05981177.pdf
[firstpage_image] =>[orig_patent_app_number] => 378548
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/378548 | Protein fusion method and constructs | Jan 24, 1995 | Issued |
Array
(
[id] => 4013862
[patent_doc_number] => 05880102
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-03-09
[patent_title] => 'Adenoviral vector system'
[patent_app_type] => 1
[patent_app_number] => 8/374483
[patent_app_country] => US
[patent_app_date] => 1995-01-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 108
[patent_figures_cnt] => 113
[patent_no_of_words] => 9281
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/880/05880102.pdf
[firstpage_image] =>[orig_patent_app_number] => 374483
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/374483 | Adenoviral vector system | Jan 16, 1995 | Issued |
Array
(
[id] => 3865933
[patent_doc_number] => 05837484
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-11-17
[patent_title] => 'Stable cell lines capable of expressing the adeno-associated virus replication gene'
[patent_app_type] => 1
[patent_app_number] => 8/362608
[patent_app_country] => US
[patent_app_date] => 1995-01-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 8
[patent_no_of_words] => 7732
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/837/05837484.pdf
[firstpage_image] =>[orig_patent_app_number] => 362608
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/362608 | Stable cell lines capable of expressing the adeno-associated virus replication gene | Jan 8, 1995 | Issued |
Array
(
[id] => 3729666
[patent_doc_number] => 05693533
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-12-02
[patent_title] => 'Human breast carcinoma cell line capable of production of a spontaneously metastasizing tumor in animals for use in anticancer drug testing'
[patent_app_type] => 1
[patent_app_number] => 8/350938
[patent_app_country] => US
[patent_app_date] => 1994-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2413
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/693/05693533.pdf
[firstpage_image] =>[orig_patent_app_number] => 350938
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/350938 | Human breast carcinoma cell line capable of production of a spontaneously metastasizing tumor in animals for use in anticancer drug testing | Dec 6, 1994 | Issued |
Array
(
[id] => 4004303
[patent_doc_number] => 06004940
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-12-21
[patent_title] => 'Intracellular targeting of endogenous proteins'
[patent_app_type] => 1
[patent_app_number] => 8/350215
[patent_app_country] => US
[patent_app_date] => 1994-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 15
[patent_no_of_words] => 16337
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/004/06004940.pdf
[firstpage_image] =>[orig_patent_app_number] => 350215
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/350215 | Intracellular targeting of endogenous proteins | Dec 5, 1994 | Issued |
Array
(
[id] => 3941146
[patent_doc_number] => 05872225
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-02-16
[patent_title] => 'Method for characterizing the nucleotide sequence of L1CAM and the nucleotide sequence characterized thereby'
[patent_app_type] => 1
[patent_app_number] => 8/341843
[patent_app_country] => US
[patent_app_date] => 1994-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 7
[patent_no_of_words] => 11079
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/872/05872225.pdf
[firstpage_image] =>[orig_patent_app_number] => 341843
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/341843 | Method for characterizing the nucleotide sequence of L1CAM and the nucleotide sequence characterized thereby | Nov 17, 1994 | Issued |
Array
(
[id] => 1542299
[patent_doc_number] => 06372502
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-04-16
[patent_title] => 'Retroviral packaging cell lines and processes of using same'
[patent_app_type] => B1
[patent_app_number] => 08/341269
[patent_app_country] => US
[patent_app_date] => 1994-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 6472
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 220
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/372/06372502.pdf
[firstpage_image] =>[orig_patent_app_number] => 08341269
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/341269 | Retroviral packaging cell lines and processes of using same | Nov 16, 1994 | Issued |
| 08/309026 | METHODS FOR GENETICALLY MODIFYING HEMATOPOIETIC STEM CELLS | Sep 18, 1994 | Abandoned |
Array
(
[id] => 4268786
[patent_doc_number] => 06245560
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-06-12
[patent_title] => 'Vector with multiple target response elements affecting gene expression'
[patent_app_type] => 1
[patent_app_number] => 8/245506
[patent_app_country] => US
[patent_app_date] => 1994-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 31
[patent_no_of_words] => 11355
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/245/06245560.pdf
[firstpage_image] =>[orig_patent_app_number] => 245506
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/245506 | Vector with multiple target response elements affecting gene expression | May 17, 1994 | Issued |
Array
(
[id] => 4335452
[patent_doc_number] => 06333175
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-12-25
[patent_title] => 'Yield when disulfide-bonded proteins are secreted'
[patent_app_type] => 1
[patent_app_number] => 8/097621
[patent_app_country] => US
[patent_app_date] => 1993-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4775
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/333/06333175.pdf
[firstpage_image] =>[orig_patent_app_number] => 097621
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/097621 | Yield when disulfide-bonded proteins are secreted | Jul 26, 1993 | Issued |